SoftBank posts unexpected $7bn loss on data centre writedown
AI-focused Japanese group blames first quarterly loss in nearly two years on ‘evolving requirements’ in US projects
SoftBank posts unexpected $7bn loss on data centre writedown
AI-focused Japanese group blames first quarterly loss in nearly two years on ‘evolving requirements’ in US projects
FilterFinancial Times
Clustered coverageFinancial Times
Coverage timeline1
Coverage timeline
Coverage timeline
Ranked reports inside the event cluster. Open any publisher link to read the original coverage.
Related events
Related events
Nearby clusters pulled from title, summary, and keyword similarity in PostgreSQL.
1 report1 sourceSimilarity 0.39
SoftBank swings to $7 billion net loss in second quarter as tech selloff weighs on results
SoftBank Group announces fiscal second-quarter results for the year ending March 31, 2027.
CNBC
1 report1 sourceSimilarity 0.36
Data centre builder Firmus says diesel generators only for emergencies
AI data centre developer Firmus Technologies has appeared before a parliamentary inquiry and given assurances it will only use diesel generators in times of emergency.
ABC Australia
1 report1 sourceSimilarity 0.36
Calls for data centre moratorium 'until we get the rules right'
The Conservation Council is calling for a moratorium on new data centre developments in the ACT until tougher rules are in place, amid "increasing concerns" about the impact on Canberra's water supply and electricity…
ABC Australia
1 report1 sourceSimilarity 0.35
Norway reins in data centre industry amid AI boom
Demand from new data centres could lead to an energy deficit and rising electricity prices in the coming years.
The Straits Times
3 reports1 sourceSimilarity 0.24
This beaten-down data center stock could be worth a look, says Mike Khouw
United Rentals is trading at a below-market forward multiple. Effectively, one can buy superior, market-beating growth at a discounted market multiple. Grouped from 3 articles across 1 sources.
CNBC
3 reports3 sourcesSimilarity 0.21
FDA warns of vision loss risk linked to popular GLP-1 drugs like Wegovy, Zepbound
The agency has found evidence of a potential increased risk of a rare eye condition linked to the use of GLP-1 drugs used for weight management and diabetes. Grouped from 3 articles across 3 sources.
ABC Australia, CNBC, Euronews